Guyer Charles Greg

Track

Insider profile

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Guyer Charles Greg's trades of Biomarin Pharmaceutical Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-12 2026-03-11
S Sale
36,003 +34.1%
180.00
US$4,954,275 		36,003 +34.1% 180.00 US$4,954,275
2026-03-11 2026-03-11
PrS Proposed sale
83,659
57.73
US$4,059,615 		83,659 57.73 US$4,059,615
2025-03-07 2025-03-06
S Sale
35,792 -9.5%
388.71
US$3,592,269 		35,792 -9.5% 388.71 US$3,592,269
2025-03-06 2025-03-06
PrS Proposed sale
7,034
71.28
US$501,359 		7,034 71.28 US$501,359
2024-11-14 2024-11-12
S Sale
5,278 -7.1%
66.37
US$350,324 		5,278 -7.1% 66.37 US$350,324
2024-11-12 2024-11-12
PrS Proposed sale
5,278
66.37
US$350,324 		5,278 66.37 US$350,324
2023-08-10 2023-08-09
S Sale
5,360 -11.8%
93.30
US$500,109 		5,360 -11.8% 93.30 US$500,109
2023-08-09 2023-08-09
PrS Proposed sale
5,360
93.30
US$500,107 		5,360 93.30 US$500,107
2022-08-10 2022-08-08
S Sale
6,205 -12.8%
96.56
US$599,155 		6,205 -12.8% 96.56 US$599,155